Antioxidants,
Journal Year:
2024,
Volume and Issue:
13(9), P. 1072 - 1072
Published: Sept. 2, 2024
Frontotemporal
dementia
(FTD)
causes
progressive
neurodegeneration
in
the
frontal
and
temporal
lobes,
leading
to
behavioral,
cognitive,
language
impairments.
With
no
effective
treatment
available,
exploring
new
therapeutic
approaches
is
critical.
Recent
research
highlights
transcription
factor
Nuclear
Factor
erythroid-derived
2-like
2
(NRF2)
as
vital
limiting
neurodegeneration,
with
its
activation
shown
mitigate
FTD-related
processes
like
inflammation.
Dimethyl
fumarate
(DMF),
an
NRF2
activator,
has
demonstrated
neuroprotective
effects
a
TAU-dependent
FTD
mouse
model,
reducing
This
suggests
DMF
repositioning
potential
for
treatment.
Until
now,
trial
had
been
conducted
analyze
effect
of
on
TDP-43-dependent
FTD.
In
this
study,
we
aimed
determine
efficacy
TDP-43-related
model
that
exhibits
early
cognitive
impairment.
Mice
received
oral
every
other
day
from
presymptomatic
symptomatic
stages.
By
post-natal
(PND)
60,
improvement
function
already
evident,
becoming
even
more
pronounced
by
PND90.
enhancement
correlates
neuroprotection
observed
dentate
gyrus
reduction
astrogliosis
stratum
lacunosum-moleculare
zone.
At
prefrontal
cortex
(PFC)
level,
also
observed,
accompanied
astrogliosis.
Collectively,
our
results
suggest
application
patients
Frontiers in Cellular Neuroscience,
Journal Year:
2025,
Volume and Issue:
18
Published: Jan. 6, 2025
Precision,
or
personalized,
medicine
aims
to
stratify
patients
based
on
variable
pathogenic
signatures
optimize
the
effectiveness
of
disease
prevention
and
treatment.
This
approach
is
favorable
in
context
brain
disorders,
which
are
often
heterogeneous
their
pathophysiological
features,
patterns
progression
treatment
response,
resulting
limited
therapeutic
standard-of-care.
Here
we
highlight
transformative
role
that
human
induced
pluripotent
stem
cell
(hiPSC)-derived
neural
models
poised
play
advancing
precision
for
particularly
emerging
innovations
improve
relevance
hiPSC
physiology.
hiPSCs
derived
from
accessible
patient
somatic
cells
can
produce
various
types
tissues;
current
efforts
increase
complexity
these
models,
incorporating
region-specific
tissues
non-neural
microenvironment,
providing
increasingly
relevant
insights
into
human-specific
neurobiology.
Continued
advances
tissue
engineering
combined
with
genomics,
high-throughput
screening
imaging
strengthen
physiological
thus
ability
uncover
mechanisms,
vulnerabilities,
fluid-based
biomarkers
will
have
real
impact
neurological
True
understanding,
however,
necessitates
integration
hiPSC-neural
biophysical
data,
including
quantitative
neuroimaging
representations.
We
discuss
recent
cellular
neuroscience
provide
direct
connections
through
generative
AI
modeling.
Our
focus
great
potential
synergy
between
pave
way
personalized
becoming
a
viable
option
suffering
neuropathologies,
rare
epileptic
neurodegenerative
disorders.
Neurology International,
Journal Year:
2025,
Volume and Issue:
17(1), P. 6 - 6
Published: Jan. 13, 2025
Neuroinflammation
is
a
blanket
term
that
describes
the
body’s
complex
inflammatory
response
in
central
nervous
system
(CNS).
It
encompasses
phenotype
shift
to
proinflammatory
state,
release
of
cytokines,
recruitment
peripheral
immune
cells,
and
wide
variety
other
processes.
has
been
implicated
nearly
every
major
CNS
disease
ranging
from
Alzheimer’s
brain
cancer.
Understanding
modeling
neuroinflammation
critical
for
identification
novel
therapeutic
targets
treatment
diseases.
Unfortunately,
translation
findings
non-human
models
left
much
be
desired.
This
review
systematically
discusses
role
human
pluripotent
stem
cell
(hPSC)-derived
glia
supporting
cells
within
CNS,
including
astrocytes,
microglia,
oligodendrocyte
precursor
pericytes,
endothelial
describe
state
field
hope
future
discoveries.
hPSC-derived
offer
an
expanded
potential
study
pathobiology
immunomodulatory
cascades
impact
progression.
While
progress
made
development
models,
there
explore
application
these
understand
CNS.
Cells,
Journal Year:
2025,
Volume and Issue:
14(6), P. 421 - 421
Published: March 12, 2025
Amyotrophic
lateral
sclerosis
(ALS)
is
a
progressive
neurodegenerative
disease
characterized
by
the
loss
of
motor
neurons,
leading
to
escalating
muscle
weakness,
atrophy,
and
eventually
paralysis.
While
neurons
are
most
visibly
affected,
emerging
data
highlight
microglia—the
brain’s
resident
immune
cells—as
key
contributors
onset
progression.
Rather
than
existing
in
simple
beneficial
or
harmful
duality,
microglia
can
adopt
multiple
functional
states
shaped
internal
external
factors,
including
those
ALS.
Collectively,
these
disease-specific
forms
called
disease-associated
(DAM).
Research
using
rodent
models,
patient-derived
cells,
human
postmortem
tissue
shows
that
transition
into
DAM
phenotypes,
driving
inflammation
neuronal
injury.
However,
cells
also
fulfill
protective
roles
under
certain
conditions,
revealing
their
adaptable
nature.
This
review
explores
recent
discoveries
regarding
multifaceted
behavior
ALS,
highlights
important
findings
link
neuron
deterioration,
discusses
therapies—some
already
used
clinical
trials—that
aim
recalibrate
microglial
functions
potentially
slow
Molecular Neurodegeneration,
Journal Year:
2025,
Volume and Issue:
20(1)
Published: March 24, 2025
Abstract
Parkinson’s
disease
(PD)
is
a
multi-system
disorder
characterized
histopathologically
by
degeneration
of
dopaminergic
neurons
in
the
substantia
nigra
pars
compacta
.
While
etiology
PD
remains
multifactorial
and
complex,
growing
evidence
suggests
that
cellular
metabolic
dysfunction
critical
driver
neuronal
death.
Defects
metabolism
related
to
energy
production,
oxidative
stress,
organelle
health,
protein
homeostasis
have
been
reported
both
immune
cells
PD.
We
propose
these
factors
act
synergistically
drive
aberrant
inflammation
CNS
periphery
PD,
contributing
hostile
inflammatory
environment
which
renders
certain
subsets
vulnerable
degeneration.
This
review
highlights
overlap
between
established
deficits
with
emerging
findings
central
peripheral
cells.
By
discussing
rapidly
expanding
literature
on
immunometabolic
we
aim
draw
attention
potential
biomarkers
facilitate
future
development
immunomodulatory
strategies
prevent
or
delay
progression
Arteriosclerosis Thrombosis and Vascular Biology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 27, 2025
BACKGROUND:
Mononuclear
phagocytes
contribute
to
pathological
angiogenesis
in
age-related
macular
degeneration,
a
leading
worldwide
cause
of
visual
impairment.
However,
the
mechanisms
that
orchestrate
functions
mononuclear
remain
poorly
understood.
TREM2
(triggering
receptor
on
myeloid
cells
2)
has
been
shown
be
crucial
for
activation
atherosclerosis,
fatty
liver
disease,
and
Alzheimer
disease.
The
objective
this
study
was
investigate
role
degeneration.
METHODS:
C57BL/6J
Trem2
knockout
mice
were
subjected
laser-induced
choroidal
neovascularization,
model
neovascular
Purified
bovine
sulfatide
agonist
anti-TREM2
antibody
used
activate
signaling.
expression
or
downstream
signals
assessed
with
immunohistochemistry
qPCR.
In
vitro
murine
macrophage
RAW264.7
direct
impact
inflammatory
phagocytic
responses.
RESULTS:
We
found
pharmacological
suppressed
neovessel
formation.
TNF
(tumor
necrosis
factor)
subsequently
promoted
phagocytosis.
CONCLUSIONS:
These
findings
demonstrate
suppresses
proinflammatory
response,
promotes
phagocytosis,
impedes
Our
provides
insight
into
critical
angiogenesis.
Journal of Neuroinflammation,
Journal Year:
2025,
Volume and Issue:
22(1)
Published: March 30, 2025
Alzheimer's
disease
(AD)
is
a
complex
neurodegenerative
disorder
characterized
by
significant
neuroinflammatory
responses.
Microglia,
the
immune
cells
of
central
nervous
system,
play
crucial
role
in
pathophysiology
AD.
Recent
studies
have
indicated
that
microglial
efferocytosis
an
important
mechanism
for
clearing
apoptotic
and
cellular
debris,
facilitating
resolution
neuroinflammation.
This
review
summarizes
biological
characteristics
microglia
mechanisms
underlying
efferocytosis,
including
factors
signaling
pathways
regulate
interactions
between
other
influence
this
process,
neuroinflammation
Furthermore,
we
explore
AD
from
three
perspectives:
its
impact
on
clearance
amyloid
plaques,
regulation
neuroinflammation,
effects
neuroprotection.
Finally,
summarize
current
research
status
enhancing
to
alleviate
improve
AD,
as
well
future
challenges
approach
therapeutic
strategy